KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 103 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $6,523,000 | +49.2% | 366,268 | -2.8% | 1.72% | +3.2% |
| Q3 2019 | $4,372,000 | -47.6% | 376,889 | 0.0% | 1.67% | -36.7% |
| Q2 2019 | $8,348,000 | -49.1% | 376,889 | -34.3% | 2.63% | -45.2% |
| Q1 2019 | $16,413,000 | +9.5% | 573,482 | -24.5% | 4.80% | -25.4% |
| Q4 2018 | $14,994,000 | -10.7% | 759,181 | 0.0% | 6.44% | +43.6% |
| Q3 2018 | $16,785,000 | +1025.0% | 759,181 | +242.5% | 4.48% | +987.9% |
| Q3 2017 | $1,492,000 | -8.5% | 221,651 | 0.0% | 0.41% | -36.7% |
| Q2 2017 | $1,631,000 | -0.2% | 221,651 | 0.0% | 0.65% | -2.7% |
| Q1 2017 | $1,635,000 | +23.7% | 221,651 | 0.0% | 0.67% | +5.5% |
| Q4 2016 | $1,322,000 | – | 221,651 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 422,310 | $10,849,000 | 5.86% |
| COMMODORE CAPITAL LP | 214,467 | $5,510,000 | 2.20% |
| Vivo Capital, LLC | 1,863,296 | $47,868,000 | 1.68% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 214,533 | $5,486,000 | 1.45% |
| Nicholas Investment Partners, LP | 594,130 | $15,263,000 | 1.06% |
| Altium Capital Management LP | 128,130 | $3,292,000 | 0.91% |
| Affinity Asset Advisors, LLC | 100,000 | $2,569,000 | 0.87% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,000 | $1,285,000 | 0.70% |
| APIS CAPITAL ADVISORS, LLC | 30,000 | $771,000 | 0.70% |
| Birchview Capital, LP | 40,000 | $1,028,000 | 0.61% |